Pharmaceutical Executive

By Pharmaceutical Executive PodcastScience Life Sciences

Pharmaceutical Executive episodes

February 10, 2025 Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement
In this episode of the Pharmaceutical Executive podcast, Bill Grambley, CEO of AllazoHealth, delves into the potential of AI to revolutionize patient engagement and adherence. By utilizing patient-level data and predictive modeling, AI can identify individual needs and preferences, tailoring interventions to optimize treatment outcomes. This personalized approach addresses the common challenges of medication non-adherence and improves patient outcomes. The discussion highlights the importance of ethical considerations and data privacy when leveraging AI in healthcare. By focusing on patient well-being and using AI responsibly, healthcare providers can significantly enhance patient experiences and improve overall health outcomes.

20 min
January 30, 2025 The Future of Fertility: AI, Personalized Medicine, and Ethical Considerations
In this episode of the Pharmaceutical Executive podcast, Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), discusses the challenges of addressing fertility misinformation on social media. He emphasizes the importance of providing accurate and reliable information and encourages patients to consult with healthcare professionals. He also discusses the ethical considerations of using social media to share personal and professional experiences in the field of fertility and so much more!
31 min
November 08, 2024 Key Findings of the NIAGARA and HIMALAYA Trials
In this episode of the Pharmaceutical Executive podcast, Shubh Goel, Head of Immuno-Oncology and Gastrointestinal Tumors, US Oncology Business Unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer, and much more.

14 min
October 25, 2024Fake Weight Loss Drugs: Growing Threat to Consumer Health
UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss:
Counterfeit weight loss drugs (particularly fake Ozempic) and potential health risks
What can be done to raise awareness among consumers about the dangers of counterfeit medications
Ways increase access to legitimate weight loss medications, especially for those in underserved communities
and much more!
22 min
September 23, 2024 A Different Approach to Dermatology Care
Brian Hillberdink, EVP, LEO Pharma and President of LEO Pharma's US affiliate, discusses how is they're positioning to capitalize on the unmet needs in other specific therapeutic areas, their approach to orphan drug development, challenges and opportunities adapting to the US market, and more.
15 min
September 06, 2024Beyond the Birthrate: The Societal Costs of Maternal Morality
In this episode of the Pharmaceutical Executive podcast, Charlotte Owens, MD, FACOG, Head of Medical Affairs and Outcomes Research at Organon discusses:
The broader societal implications of these maternal health issues highlighted in The Commonwealth Fund study
The most critical changes needed to close the gaps in R&D for maternal health solutions and how feasible they are to make
Specific efforts Organon is undertaking to invest in research, education, and its pipeline to focus on critical areas of need in maternal health
How her in-practice experience as an OB-GYN are informing Organon's strategic approach to addressing maternal health challenges
and more!
16 min
August 05, 2024 Empty Shelves, Urgent Solutions
Michael Abrams, Managing Partner at Numerof & Associates discusses pharmacy deserts and the main factors that are contributing to the closures of both large and independent pharmacies, what alternative solutions can help ensure continued access to medications for all Americans (particularly those in underserved communities), some potential long term consequences if these pharmacy closures continue, and so much more
19 min
July 11, 2024The Weight-Loss Gold Rush: Legal and Regulatory Implications
Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses:
Top legal and regulatory concerns for investors considering when financing companies developing or marketing GLP-1 drugs
How the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs
What needs to be done for GLP-1s to be covered
Steps companies developing weight-loss medications should take to ensure responsible and ethical practice
Advice for investors and financiers who are considering entering the weight-loss medication market
18 min
May 14, 2024 Healthcare Marketing Strategies for Reaching Diverse Audiences
Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.

Link to Honeycomb Health video: https://www.pharmexec.com/view/going-beyond-visuals-to-connect-with-diverse-audiences
14 min
April 30, 2024 A Decade in the Anti-Obesity Arena
Currax Pharmaceuticals CEO, George Hampton discusses what patient success has looked like for their oral anti-obesity medication, how expanded access can help with the world's obesity epidemic, when prices should come down, and much more.
23 min